Researchers developed a novel drug screening system to identify a compound that mimics the changes in muscle and bone that occur as a result of exercise.
read more
A three-drug medication known as a “polypill” is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.
read more
A team has debuted a new preclinical drug candidate—JSF-2659—that shows promise in eradicating the bacteria that causes gonorrhea.
read more
New research part of a global project involving patients in intensive care has highlighted that propofol, an anaesthetic drug commonly used to facilitate invasive mechanical ventilation, increases cardiovascular complications risk in the critically ill.
read more
Researchers have discovered that bacteria are more “crafty” than previously thought when it comes to resisting antibiotics.
read more
The team developed a novel algorithm that identified nearly 20,000 ADEs signals—information on a new or known side effect that may be caused by a drug—across the seven pediatric development stages.
read more
Researchers have developed a novel approach to overcome the challenges presented by antibiotic-resistant infections.
read more
Nipah virus infection is a zoonotic disease, meaning that it is spread between animals and people. Fruit bats are the natural host for the virus.
read more
Bioscientists have designed novel on and off switches to control the “silent” genes in a strain of bacteria. Their strategy could boost the perpetual search for new antibiotics.
read more
In a new paper, researchers say they may have found the answer to the conundrum of S. aureus, including the mechanism that explains why vaccine trials have so far failed and ways to overcome that.
read more
The biocompatible, water-soluble device works by softly wrapping around nerves to deliver precise, targeted cooling, which numbs nerves and blocks pain signals to the brain.
read more
BPL-1357 is a whole-virus vaccine made up of four strains of non-infectious, chemically inactivated, low-pathogenicity avian flu virus.
read more
The study examined the engineering of type B white blood cells in the patient's body so as to secrete anti-HIV antibodies in response to the virus.
read more
The compound, named cilagicin, works well in mice and employs a novel mechanism to attack MRSA, C. diff, and several other deadly pathogens.
read more
A global study of asthma patients by Rutgers and an international team of researchers found a combination of two drugs dramatically reduces the chances of suffering an asthma attack.
read more